第 1 到 5 筆結果,共 5 筆。
公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 | |
---|---|---|---|---|---|---|---|
1 | 2017 | Polymorphisms of ESR1, UGT1A1, HCN1, MAP3K1 and CYP2B6 are associated with the prognosis of hormone receptor-positive early breast cancer | SUNG-HSIN KUO ; Yang S.-Y.; You S.-L.; HUANG-CHUN LIEN ; CHING-HUNG LIN ; PO-HAN LIN ; CHIUN-SHENG HUANG | Oncotarget | 35 | 30 | |
2 | 2013 | CYP19 genetic polymorphism haplotype aasa is associated with a poor prognosis in premenopausal women with lymph node-negative, hormone receptor-positive breast cancer | SUNG-HSIN KUO ; Yang, Shi-Yi; HUANG-CHUN LIEN ; Chiao Lo ; CHING-HUNG LIN ; YEN-SHEN LU ; ANN-LII CHENG ; KING-JEN CHANG ; CHIUN-SHENG HUANG | BioMed Research International | 9 | 9 | |
3 | 2010 | Fractionated evaluation of immunohistochemical hormone receptor expression enhances prognostic prediction in breast cancer patients treated with tamoxifen as adjuvant therapy | CHING-HUNG LIN ; HUANG-CHUN LIEN ; Hu F.-C.; YEN-SHEN LU ; SUNG-HSIN KUO ; Wu L.-C.; You S.-L.; ANN-LII CHENG ; KING-JEN CHANG ; CHIUN-SHENG HUANG | Journal of Zhejiang University: Science B | 8 | 11 | |
4 | 2008 | The CYP19 TTTA repeat polymorphism is related to the prognosis of premenopausal stage I-II and operable stage III breast cancers | CHIUN-SHENG HUANG ; SUNG-HSIN KUO ; HUANG-CHUN LIEN ; Yang S.-Y.; You S.-L.; Shen C.-Y.; CHING-HUNG LIN ; YEN-SHEN LU ; KING-JEN CHANG | Oncologist | 19 | 18 | |
5 | 2008 | Dose variation and regimen modification of adjuvant chemotherapy in daily practice affect survival of stage I-II and operable stage III Taiwanese breast cancer patients | SUNG-HSIN KUO ; HUANG-CHUN LIEN ; You S.-L.; YEN-SHEN LU ; CHING-HUNG LIN ; Chen T.-Z.; CHIUN-SHENG HUANG | Breast | 13 | 12 |